Self-monitoring Blood Glucose Devices Market (Updated Version Available)

Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens. It can be used to aid in the adjustment of a therapeutic regimen in response to blood glucose values and to help individuals adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a day-to-day basis.
The classification of self-monitoring blood glucose (SMBG) devices includes strips, glucose meter and lancet. The revenue proportion of strips in 2017 is about 85.08%, and the proportion is in increasing trend from 2013 to 2017.
Self-monitoring blood glucose (SMBG) devices is widely sold in public hospital, private hospital, clinics and pharmacy shops. The most proportion of self-monitoring blood glucose (SMBG) devices is sold in pharmacy shops, and the proportion in 2017is about 50.02%.
Central Thailand is the largest sales place, with a sales market share nearly 45.92% in 2017. Following Central Thailand, Northern Thailand is the second largest sales place with the market share of 24.97%.
The report comprises of key players profiles namely consignment, price, revenue, profit interview records and sources of distribution. It helps clients get a better analysis of their competitors. In addition, it encompasses the regions and countries across the world and depicts the regional outlook, market size, volume, value and price data.
The Self-monitoring Blood Glucose Devices market was valued at xxx million USD with a CAGR xx% from 2015-2019. Subsequently, it will touch xxx million USD in 2020 with a CAGR xx % from 2020 to 2025.
Global market, the following companies are covered:
Roche Roche Diagnostics
Lifescan
Abbott Laboratories
Terumo
Ascensia (Bayer)
...

Market Segment by Product Type
Strips
Glucose Meter
Lancet
Other

Market Segment by Application
Public Hospital
Private Hospital
Clinics
Pharmacy Shops

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Self-monitoring Blood Glucose Devices market for the forecast period 2020 - 2025?
• What are the driving forces in the Self-monitoring Blood Glucose Devices market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Self-monitoring Blood Glucose Devices industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?